Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |